MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
MetLife, Inc.NYSE: MET
Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026
Income tax expense growth accelerates
Q2 FY2026 income tax expense of $256M rose 4.5% year over year, ahead of the -14.1% change in trailing-twelve-month income tax expense. Sequentially, it fell 25.8% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Income tax expense amounted to 1.6% of revenue in FY2025, unchanged from a year earlier.
- Income tax expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +4.5% holds above the trailing-twelve-month pace of -14.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 1.26B USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- -6.4%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.26B | +6.8% |
| FY2024 | 2024-12-31 | 1.18B | +110.4% |
| FY2023 | 2023-12-31 | 560M | -47.3% |
| FY2022 | 2022-12-31 | 1.06B | -35.3% |
| FY2021 | 2021-12-31 | 1.64B | — |
Income Tax Expense vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -14.1% is the 9th highest of 11, against a peer median of +11.4%.
- Income tax expense amounts to 1.5% of revenue for MET, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CA$1.3B CAD | +19.2% | — | 2.3% | |
| LTM Jun 2026 | $1.21B USD | -14.1% | +5.8% | 1.5% | |
| LTM Jun 2026 | $998M USD | +180.3% | — | 1.5% | |
| LTM Jun 2026 | $924M USD | +22.1% | +25.3% | 5.1% | |
| LTM Jun 2026 | $477M USD | +198.1% | -24.0% | 2.5% | |
| LTM Sep 2026 | $278.12M USD | +3.6% | +10.3% | 4.4% | |
| LTM Sep 2026 | $228.08M USD | +1.8% | +10.9% | 6.6% | |
| LTM Jun 2026 | $202.4M USD | -49.6% | -17.1% | 1.5% | |
| LTM Sep 2026 | $109M USD | -41.4% | -65.1% | 2.0% | |
| LTM Jun 2026 | $106M USD | +60.6% | — | 2.8% | |
| LTM Jun 2026 | $76.1M USD | -0.3% | -29.9% | 1.6% | |
| Peer median (excluding MET) | — | +11.4% | -17.1% | 2.4% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.